Press releases 2023

XNK Therapeutics one of three winners of Business Sweden’s Catalyst program 2023

XNK Therapeutics AB announced July 12, 2023 that it has been selected as one of three winners of Business Sweden’s Catalyst program 2023. The program identifies Swedish companies having the strongest prerequisites to scale up globally.

PRESS RELEASE BY: XNK THERAPEUTICS 2023-07-12

XNK receives certificate of GMP compliance of a manufacturer from the Medical Products Agency

XNK Therapeutics announced March 20, 2023 that XNK has received a GMP manufacturing license and a certificate of GMP compliance from the Swedish Medical Products Agency, which means that the company can produce at scale for its planned clinical studies.

PRESS RELEASE BY: XNK THERAPEUTICS 2023-03-20

One scientist is looking in a microscope another scientist is standing next to him. Both have yellow clothes.
Photo: Ulf Sirborn
HL
Content reviewer:
12-02-2024